Intuitive Surgical (NASDAQ:ISRG) Rating Lowered to Hold at Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

A number of other equities research analysts have also weighed in on the company. Leerink Partners boosted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Raymond James Financial lifted their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Argus dropped their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday. UBS Group reissued a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. Finally, Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $488.15 on Friday. The company has a market capitalization of $173.36 billion, a P/E ratio of 61.87, a P/E/G ratio of 3.70 and a beta of 1.65. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $609.08. The company has a fifty day moving average of $549.63 and a 200-day moving average of $510.54.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period last year, the firm posted $2.21 EPS. As a group, analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 126 shares of the business’s stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total value of $65,522.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 73,616 shares of company stock valued at $40,929,575 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Intuitive Surgical

A number of institutional investors have recently made changes to their positions in the stock. Tobam lifted its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Holos Integrated Wealth LLC bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Finally, Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $27,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.